• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活化的凝血因子XI去除ADAMTS13的C末端结构域可诱导流动条件下血小板在内皮细胞上的黏附。

Removal of the C-Terminal Domains of ADAMTS13 by Activated Coagulation Factor XI induces Platelet Adhesion on Endothelial Cells under Flow Conditions.

作者信息

Garland Kathleen S, Reitsma Stéphanie E, Shirai Toshiaki, Zilberman-Rudenko Jevgenia, Tucker Erik I, Gailani David, Gruber András, McCarty Owen J T, Puy Cristina

机构信息

Division of Pediatric Hematology/Oncology, School of Medicine, Oregon Health & Science University, Portland, OR, United States.

Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR, United States.

出版信息

Front Med (Lausanne). 2017 Dec 20;4:232. doi: 10.3389/fmed.2017.00232. eCollection 2017.

DOI:10.3389/fmed.2017.00232
PMID:29326937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5742325/
Abstract

Platelet recruitment to sites of vascular injury is mediated by von Willebrand factor (VWF). The shear-induced unraveling of ultra-large VWF multimers causes the formation of a "stringlike" conformation, which rapidly recruits platelets from the bloodstream. A disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) regulates this process by cleaving VWF to prevent aberrant platelet adhesion; it is unclear whether the activity of ADAMTS13 itself is regulated. The serine proteases α-thrombin and plasmin have been shown to cleave ADAMTS13. Based on sequence homology, we hypothesized that activated coagulation factor XI (FXIa) would likewise cleave ADAMTS13. Our results show that FXIa cleaves ADAMTS13 at the C-terminal domains, generating a truncated ADAMTS13 with a deletion of part of the thrombospondin type-1 domain and the CUB1-2 domains, while α-thrombin cleaves ADAMTS13 near the CUB1-2 domains and plasmin cleaves ADAMTS13 at the metalloprotease domain and at the C-terminal domain. Using a cell surface immunoassay, we observed that FXIa induced the deletion of the CUB1-2 domains from ADAMTS13 on the surface of endothelial cells. Removal of the C-terminal domain of ADAMTS13 by FXIa or α-thrombin caused an increase in ADAMTS13 activity as measured by a fluorogenic substrate (FRETS) and blocked the ability of ADAMTS13 to cleave VWF on the endothelial cell surface, resulting in persistence of VWF strands and causing an increase in platelet adhesion under flow conditions. We have demonstrated a novel mechanism for coagulation proteinases including FXIa in regulating ADAMTS13 activity and function. This may represent an additional hemostatic function by which FXIa promotes local platelet deposition at sites of vessel injury.

摘要

血小板募集到血管损伤部位是由血管性血友病因子(VWF)介导的。剪切力诱导超大VWF多聚体解聚,形成“丝状”构象,迅速从血流中募集血小板。具有血小板反应蛋白1型基序的解聚素和金属蛋白酶13(ADAMTS13)通过切割VWF来调节这一过程,以防止异常的血小板黏附;尚不清楚ADAMTS13自身的活性是否受到调节。丝氨酸蛋白酶α-凝血酶和纤溶酶已被证明可切割ADAMTS13。基于序列同源性,我们推测活化的凝血因子XI(FXIa)同样会切割ADAMTS13。我们的结果表明,FXIa在C末端结构域切割ADAMTS13,产生一种截短的ADAMTS13,缺失部分血小板反应蛋白1型结构域和CUB1-2结构域,而α-凝血酶在CUB1-2结构域附近切割ADAMTS13,纤溶酶在金属蛋白酶结构域和C末端结构域切割ADAMTS13。使用细胞表面免疫测定法,我们观察到FXIa诱导内皮细胞表面的ADAMTS13缺失CUB1-2结构域。FXIa或α-凝血酶去除ADAMTS13的C末端结构域导致以荧光底物(FRETS)测量的ADAMTS13活性增加,并阻断了ADAMTS13在内皮细胞表面切割VWF的能力,导致VWF链持续存在,并在流动条件下导致血小板黏附增加。我们已经证明了包括FXIa在内的凝血蛋白酶调节ADAMTS13活性和功能的新机制。这可能代表FXIa促进血管损伤部位局部血小板沉积的另一种止血功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0c/5742325/8ed066a745f8/fmed-04-00232-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0c/5742325/cd60a39c5e4f/fmed-04-00232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0c/5742325/17736300156d/fmed-04-00232-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0c/5742325/149564c87a9a/fmed-04-00232-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0c/5742325/ad3350592fe6/fmed-04-00232-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0c/5742325/9af87090bf74/fmed-04-00232-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0c/5742325/8ed066a745f8/fmed-04-00232-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0c/5742325/cd60a39c5e4f/fmed-04-00232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0c/5742325/17736300156d/fmed-04-00232-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0c/5742325/149564c87a9a/fmed-04-00232-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0c/5742325/ad3350592fe6/fmed-04-00232-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0c/5742325/9af87090bf74/fmed-04-00232-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0c/5742325/8ed066a745f8/fmed-04-00232-g006.jpg

相似文献

1
Removal of the C-Terminal Domains of ADAMTS13 by Activated Coagulation Factor XI induces Platelet Adhesion on Endothelial Cells under Flow Conditions.活化的凝血因子XI去除ADAMTS13的C末端结构域可诱导流动条件下血小板在内皮细胞上的黏附。
Front Med (Lausanne). 2017 Dec 20;4:232. doi: 10.3389/fmed.2017.00232. eCollection 2017.
2
Truncation of ADAMTS13 by Plasmin Enhances Its Activity in Plasma.纤溶酶切 ADAMTS13 可增强其在血浆中的活性。
Thromb Haemost. 2018 Mar;118(3):471-479. doi: 10.1055/s-0038-1627460. Epub 2018 Mar 13.
3
Structure and function of snake venom toxins interacting with human von Willebrand factor.与人类血管性血友病因子相互作用的蛇毒毒素的结构与功能
Toxicon. 2005 Jun 15;45(8):1075-87. doi: 10.1016/j.toxicon.2005.02.023. Epub 2005 Apr 22.
4
[Platelet--vessel wall interactions].[血小板与血管壁的相互作用]
Therapie. 2006 Sep-Oct;61(5):371-8. doi: 10.2515/therapie:2006068.
5
Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation.ADAMTS13 的系统发生和功能分析确定了高度保守的结构域,这些结构域对于别构调节至关重要。
Blood. 2019 Apr 25;133(17):1899-1908. doi: 10.1182/blood-2018-11-886275. Epub 2019 Jan 30.
6
Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.纤维蛋白溶酶对血管性血友病因子的裂解作用可作为血栓性微血管病中 ADAMTS13 缺乏症的紧急旁路。
Circulation. 2014 Mar 25;129(12):1320-31. doi: 10.1161/CIRCULATIONAHA.113.006727. Epub 2014 Jan 21.
7
The WXXW motif in the TSR1 of ADAMTS13 is important for its secretion and proteolytic activity.ADAMTS13 的 TSR1 中的 WXXW 基序对其分泌和蛋白水解活性很重要。
Thromb Res. 2013 Jun;131(6):529-34. doi: 10.1016/j.thromres.2013.04.024. Epub 2013 May 14.
8
Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies.遗传性和获得性血栓性微血管病中ADAMTS13与血管性血友病因子的相互作用
Semin Hematol. 2005 Jan;42(1):56-62. doi: 10.1053/j.seminhematol.2004.09.008.
9
Plasmin Cleaves Von Willebrand Factor at K1491-R1492 in the A1-A2 Linker Region in a Shear- and Glycan-Dependent Manner In Vitro.纤溶酶在体外以剪切和聚糖依赖的方式切割A1-A2连接区中K1491-R1492位点的血管性血友病因子。
Arterioscler Thromb Vasc Biol. 2017 May;37(5):845-855. doi: 10.1161/ATVBAHA.116.308524. Epub 2017 Mar 9.
10
Proteolytic inactivation of ADAMTS13 by plasmin in human plasma: risk of thrombotic thrombocytopenic purpura.人血浆中纤溶酶对 ADAMTS13 的蛋白水解失活:血栓性血小板减少性紫癜的风险。
J Biochem. 2018 May 1;163(5):381-389. doi: 10.1093/jb/mvx084.

引用本文的文献

1
Development of a protease-resistant ADAMTS13 to improve stability against proteolytic degradation.开发一种抗蛋白酶的ADAMTS13以提高其对蛋白水解降解的稳定性。
Blood Adv. 2025 Jun 10;9(11):2695-2705. doi: 10.1182/bloodadvances.2024015212.
2
Removal of endothelial surface-associated von villebrand factor suppresses accelerate datherosclerosis after myocardial infarction.去除内皮表面相关的 von Willebrand 因子可抑制心肌梗死后加速的动脉粥样硬化。
J Transl Med. 2024 May 1;22(1):412. doi: 10.1186/s12967-024-05231-6.
3
Optimization of plasma-based BioID identifies plasminogen as a ligand of ADAMTS13.

本文引用的文献

1
A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor.一种由血管性血友病因子介导的结构静止型金属蛋白酶ADAMTS13构象激活模型。
J Biol Chem. 2017 Apr 7;292(14):5760-5769. doi: 10.1074/jbc.M117.776732. Epub 2017 Feb 16.
2
Assessment of roles for the Rho-specific guanine nucleotide dissociation inhibitor Ly-GDI in platelet function: a spatial systems approach.Rho特异性鸟嘌呤核苷酸解离抑制剂Ly-GDI在血小板功能中的作用评估:一种空间系统方法。
Am J Physiol Cell Physiol. 2017 Apr 1;312(4):C527-C536. doi: 10.1152/ajpcell.00274.2016. Epub 2017 Feb 1.
3
基于等离子体的 BioID 的优化将纤溶酶原鉴定为 ADAMTS13 的配体。
Sci Rep. 2024 Apr 20;14(1):9073. doi: 10.1038/s41598-024-59672-6.
4
Biology of factor XI.因子 XI 的生物学。
Blood. 2024 Apr 11;143(15):1445-1454. doi: 10.1182/blood.2023020719.
5
Cattle-FRETS71, a novel fluorogenic substrate with broad applicability for characterizing ADAMTS13 properties and function.牛-FRETS71,一种新型荧光底物,具有广泛的适用性,可用于表征 ADAMTS13 的特性和功能。
J Thromb Haemost. 2023 Dec;21(12):3393-3401. doi: 10.1016/j.jtha.2023.08.016. Epub 2023 Aug 25.
6
Mechanisms of ADAMTS13 regulation.ADAMTS13 的调控机制。
J Thromb Haemost. 2022 Dec;20(12):2722-2732. doi: 10.1111/jth.15873. Epub 2022 Sep 22.
7
Chronic edible dosing of Δ9-tetrahydrocannabinol (THC) in nonhuman primates reduces systemic platelet activity and function.慢性食用 Δ9-四氢大麻酚(THC)会降低非人类灵长类动物的全身血小板活性和功能。
Am J Physiol Cell Physiol. 2022 Mar 1;322(3):C370-C381. doi: 10.1152/ajpcell.00373.2021. Epub 2022 Jan 26.
8
Cross-Talk between the Complement Pathway and the Contact Activation System of Coagulation: Activated Factor XI Neutralizes Complement Factor H.补体途径与凝血接触激活系统的串扰:激活的因子 XI 中和补体因子 H。
J Immunol. 2021 Apr 15;206(8):1784-1792. doi: 10.4049/jimmunol.2000398.
9
Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients.脓毒症和非脓毒症 ICU 患者 ADAMTS13 和血管性血友病因子水平的特征。
PLoS One. 2021 Feb 19;16(2):e0247017. doi: 10.1371/journal.pone.0247017. eCollection 2021.
10
Whole Blood Based Multiparameter Assessment of Thrombus Formation in Standard Microfluidic Devices to Proxy In Vivo Haemostasis and Thrombosis.基于全血的标准微流控装置中血栓形成的多参数评估以模拟体内止血和血栓形成
Micromachines (Basel). 2019 Nov 16;10(11):787. doi: 10.3390/mi10110787.
ADAMTS13 and von Willebrand factor interactions.
凝血酶敏感素-13与血管性血友病因子的相互作用。
Curr Opin Hematol. 2015 Sep;22(5):452-9. doi: 10.1097/MOH.0000000000000169.
4
The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family.ADAMTS(含血小板反应蛋白基序的解聚素和金属蛋白酶)家族。
Genome Biol. 2015 May 30;16(1):113. doi: 10.1186/s13059-015-0676-3.
5
Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor.活化的因子XI通过使组织因子途径抑制剂失活来增加外源性途径的促凝血活性。
Blood. 2015 Feb 26;125(9):1488-96. doi: 10.1182/blood-2014-10-604587. Epub 2015 Jan 13.
6
Allosteric activation of ADAMTS13 by von Willebrand factor.血管性血友病因子对ADAMTS13的变构激活作用。
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18584-9. doi: 10.1073/pnas.1413282112. Epub 2014 Dec 15.
7
Conformational activation of ADAMTS13.ADAMTS13的构象激活
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18578-83. doi: 10.1073/pnas.1411979112. Epub 2014 Dec 15.
8
Factor XI antisense oligonucleotide for prevention of venous thrombosis.XI 因子反义寡核苷酸预防静脉血栓形成。
N Engl J Med. 2015 Jan 15;372(3):232-40. doi: 10.1056/NEJMoa1405760. Epub 2014 Dec 7.
9
The mechanism underlying activation of factor IX by factor XIa.因子 XIa 激活因子 IX 的机制。
Thromb Res. 2014 May;133 Suppl 1(0 1):S48-51. doi: 10.1016/j.thromres.2014.03.020.
10
Evidence for factor IX-independent roles for factor XIa in blood coagulation.凝血因子XIa在血液凝固中不依赖凝血因子IX的作用的证据。
J Thromb Haemost. 2013 Dec;11(12):2118-27. doi: 10.1111/jth.12435.